When should patients and family members undergo genetic assessment for a heart condition? Find out in an international consensus document published in EP Europace, a journal of the European Society of Cardiology (ESC) and ...
Apr 4, 2022
0
0
A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session ...
Apr 3, 2022
0
6
Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.
Apr 3, 2022
0
32
Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between two life-threatening heart conditions that are often ...
Feb 23, 2022
0
17
Modeling the heart in 3D using combined imaging techniques can help predict heart rhythm abnormalities, or arrhythmias, in patients with a genetic heart disease, shows a study published today in eLife.
Jan 25, 2022
0
12
How can you mend a broken heart? According to researchers from Japan, in some cases gene replacement therapy just might do the trick.
Jan 24, 2022
0
4
Researchers from Osaka University found a previously unknown gene mutation that can cause an incurable heart condition called dilated cardiomyopathy. This gene, BAC5, is important for the movement of calcium ions in the heart ...
Jan 19, 2022
0
73
The unique beat of each person's timed ticker has been pronounced just as identifiable as a fingerprint by some biotech companies. And while each heart may beat to a different rhythm, this rhythm should remain steady—patterned ...
Dec 16, 2021
0
40
In recent decades, implantable cardioverter-defibrillator (ICD) use in the management of patients with hypertrophic cardiomyopathy (HCM) has increased. However, a new Mayo Clinic study finds that ICDs are not used as often ...
Dec 7, 2021
0
7
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical ...
Nov 17, 2021
0
75
